• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性开角型青光眼与非青光眼正常人群小梁网细胞密度

Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals.

作者信息

Alvarado J, Murphy C, Juster R

出版信息

Ophthalmology. 1984 Jun;91(6):564-79. doi: 10.1016/s0161-6420(84)34248-8.

DOI:10.1016/s0161-6420(84)34248-8
PMID:6462622
Abstract

The trabecular meshwork cellularity (cells/unit tissue area) was compared in patients with primary open-angle glaucoma (POAG) with that of nonglaucomatous (NG) individuals. The NG specimens (n = 69) include specimens from the prenatal period (n = 14) as well as the postnatal period to age 98 years (n = 55). The glaucoma specimens (n = 49) covered a wide-range of ages (23-80 years) and were obtained at trabeculectomy (n = 31) or at autopsy (n = 18). Our results show that the trabecular cellularity in NG specimens decreases most rapidly and in a nonlinear manner in the late fetal period and for the first few years of postnatal life. This rapid decline in cellularity then slows down to proceed in a nearly linear manner for the remainder of the 98 years of life studied. The meshworks from patients with POAG have a lower cellularity than normals over the wide range of ages examined, but both types of specimens undergo similar declines in cellularity with age. Thus, the age-cellularity curves for both the NG and POAG specimens are parallel to each other. The loss of cells occurs in a gradient-like manner with the inner tissues being most affected and the outermost tissues least affected. A variety of statistical tests show that these changes in cellularity are highly significant and specific. These findings are compared to the loss of endothelial cells in the cornea and they are discussed in relation to the important clinical characteristics of POAG.

摘要

对原发性开角型青光眼(POAG)患者小梁网细胞密度(细胞数/单位组织面积)与非青光眼(NG)个体进行了比较。NG标本(n = 69)包括产前阶段的标本(n = 14)以及出生后至98岁的标本(n = 55)。青光眼标本(n = 49)涵盖了广泛的年龄范围(23 - 80岁),通过小梁切除术(n = 31)或尸检(n = 18)获得。我们的结果表明,NG标本中的小梁细胞密度在胎儿后期和出生后最初几年下降最快且呈非线性。这种细胞密度的快速下降随后减缓,在研究的98年剩余时间里以近乎线性的方式进行。在检查的广泛年龄范围内,POAG患者的小梁网细胞密度低于正常人,但两种类型的标本随着年龄增长细胞密度下降情况相似。因此,NG和POAG标本的年龄 - 细胞密度曲线相互平行。细胞丢失呈梯度样方式发生,内部组织受影响最大,最外层组织受影响最小。各种统计测试表明,这些细胞密度变化具有高度显著性和特异性。将这些发现与角膜内皮细胞的丢失进行了比较,并结合POAG的重要临床特征进行了讨论。

相似文献

1
Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals.原发性开角型青光眼与非青光眼正常人群小梁网细胞密度
Ophthalmology. 1984 Jun;91(6):564-79. doi: 10.1016/s0161-6420(84)34248-8.
2
Juxtacanalicular tissue in primary open angle glaucoma and in nonglaucomatous normals.原发性开角型青光眼和非青光眼正常眼中的小梁网组织。
Arch Ophthalmol. 1986 Oct;104(10):1517-28. doi: 10.1001/archopht.1986.01050220111038.
3
Age-related changes in trabecular meshwork cellularity.小梁网细胞数量的年龄相关性变化。
Invest Ophthalmol Vis Sci. 1981 Nov;21(5):714-27.
4
Differences in the trabecular meshwork between Belgian and Congolese patients with open-angle glaucoma.
Bull Soc Belge Ophtalmol. 1997;267:183-90.
5
Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma (POAG).原发性开角型青光眼(POAG)未经治疗病例中小梁网的超微结构。
Exp Eye Res. 1993 Jun;56(6):683-92. doi: 10.1006/exer.1993.1085.
6
Melanin in the trabecular meshwork is associated with age, POAG but not Latanoprost treatment. A masked morphometric study.小梁网中的黑色素与年龄、原发性开角型青光眼相关,但与拉坦前列素治疗无关。一项盲法形态计量学研究。
Exp Eye Res. 2006 Jun;82(6):986-93. doi: 10.1016/j.exer.2005.10.009. Epub 2005 Nov 17.
7
Aqueous humor stimulates the migration of human trabecular meshwork cells in vitro.房水在体外刺激人小梁网细胞迁移。
Invest Ophthalmol Vis Sci. 2000 Apr;41(5):1091-8.
8
Localization of elastin in the normal and glaucomatous human trabecular meshwork.弹性蛋白在正常和青光眼患者人小梁网中的定位。
Invest Ophthalmol Vis Sci. 1994 Feb;35(2):486-94.
9
[Morphological alterations of the trabecular meshwork in primary open angle glaucoma].
Arch Soc Esp Oftalmol. 2000 Mar;75(3):159-64.
10
Morphological Abnormalities of Schlemm's Canal in Primary Open-Angle Glaucoma From the Aspect of Aging.从衰老角度看原发性开角型青光眼中施莱姆管的形态学异常
Invest Ophthalmol Vis Sci. 2016 Feb;57(2):692-706. doi: 10.1167/iovs.15-17127.

引用本文的文献

1
Pharmacogenomics of steroid-induced ocular hypertension: relationship to high-tension glaucomas and new pathophysiologic insight.类固醇性高眼压症的药物基因组学:与高眼压型青光眼的关系及新的病理生理学见解
medRxiv. 2025 Aug 13:2025.08.11.25333245. doi: 10.1101/2025.08.11.25333245.
2
Selective Laser Trabeculoplasty and the Evolving Glaucoma Paradigm.选择性激光小梁成形术与不断发展的青光眼治疗模式
Ophthalmol Glaucoma. 2025 Jul 26. doi: 10.1016/j.ogla.2025.06.010.
3
Methods for Mitochondrial DNA Damage and Depletion in Immortalized Trabecular Meshwork Cells.
永生化小梁网细胞中线粒体DNA损伤与耗竭的方法
Int J Mol Sci. 2025 Jun 28;26(13):6255. doi: 10.3390/ijms26136255.
4
Magnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma.磁导向细胞疗法降低眼压作为开角型青光眼的一种治疗策略。
Elife. 2025 Jul 7;13:RP103256. doi: 10.7554/eLife.103256.
5
Protein misfolding and mitochondrial dysfunction in glaucoma.青光眼患者的蛋白质错误折叠与线粒体功能障碍
Front Cell Dev Biol. 2025 Apr 25;13:1595121. doi: 10.3389/fcell.2025.1595121. eCollection 2025.
6
Exploring diagnostic m6A regulators in primary open-angle glaucoma: insight from gene signature and possible mechanisms by which key genes function.探索原发性开角型青光眼中的诊断性m6A调控因子:来自基因特征的见解以及关键基因发挥作用的可能机制
BMC Med Genomics. 2025 Mar 24;18(1):57. doi: 10.1186/s12920-025-02123-6.
7
Identification of a chromatin regulator signature and potential candidate drugs for primary open-angle glaucoma.原发性开角型青光眼染色质调节因子特征及潜在候选药物的鉴定
Epigenomics. 2025 Apr;17(6):377-387. doi: 10.1080/17501911.2025.2479420. Epub 2025 Mar 17.
8
Characterization, Enrichment, and Computational Modeling of Cross-Linked Actin Networks in Transformed Trabecular Meshwork Cells.转化小梁网细胞中交联肌动蛋白网络的表征、富集及计算建模
Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):65. doi: 10.1167/iovs.66.2.65.
9
Emerging trends in long-acting sustained drug delivery for glaucoma management.青光眼治疗中长效缓释药物递送的新趋势。
Drug Deliv Transl Res. 2025 Jun;15(6):1907-1934. doi: 10.1007/s13346-024-01779-4. Epub 2025 Jan 9.
10
Trabecular meshwork ultrastructural changes in primary and secondary glaucoma.原发性和继发性青光眼小梁网的超微结构变化
Sci Rep. 2025 Jan 2;15(1):138. doi: 10.1038/s41598-024-83834-1.